drugset / Trial / NCT04563260

Effect of Palonosetron on Remifentanil for Preventing Emergence Cough in Female

NCT04563260

Completed 45 enrolled Ajou University School of Medicine
RandomizedParallel-groupTriple-blindPrevention

Summary

The primary purpose of this study is to investigate the optimal Ce of remifentanil for preventing emergence cough following extubation during general anesthesia in female patients who receive the palonosetron or not.

Timeline

Start
2020-10-07
Primary completion
2021-03-19
Completion
2021-03-19

Drugs

EvaluationDrugModalityDoseRoute
Subject Palonosetron Other / unclassified 0.075 mg Intravenous

Indications